Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 580 participants.

Also called NCT06242145

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 580 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT06242145
Other papers using this trial's data
  • Cilostazole versus clopidogrel in acute large-vessel moderate and moderate-to-severe ischemic stroke: a randomized controlled trial Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2025-08 DOI, PubMed 40232632, PMC12267345 In the PMC Open Access subset under CC BY.

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
Egypt (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT06242145. Randomized; double masking; primary purpose treatment. Start 2023-01-01 (actual); primary completion 2024-07-01 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Clopidogrel Versus Cilostazol in Large-vessel Ischemic Stroke
Intervention (Drug)
Clopidogrel tablet
Intervention (Drug)
Cilostazol 100 MG
Lead sponsor
Kafrelsheikh University (class: other)

Record details

Record id
cardio:ct-nct06242145
Content hash
536fbc6a459885b71420f45dc015a1dfaaa88fafdaf116b71cce04ed323a72fa